|
WO2005001044A2
|
|
Compositions related to pleiotrophin methods and uses thereof
|
|
EP1225885A2
|
|
A therapeutic mixture of hmg-coa reductase inhibitors
|
|
EP1150669A1
|
|
L-arginine based formulations for treating diseases and methods of using same
|
|
EP1671630A2
|
|
L-Arginine based formulations for treating diseases and methods of using the same
|
|
AU3495599A
|
|
Therapeutic angiogenic factors and methods for their use
|
|
EP1552745A1
|
|
Therapeutic combinations of venous dilators and arterial dilators
|
